» Articles » PMID: 28685508

Diabetes-Related Cardiac Dysfunction

Overview
Specialty Endocrinology
Date 2017 Jul 8
PMID 28685508
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

The proposal that diabetes plays a role in the development of heart failure is supported by the increased risk associated with this disease, even after correcting for all other known risk factors. However, the precise mechanisms contributing to the condition referred to as diabetic cardiomyopathy have remained elusive, as does defining the disease itself. Decades of study have defined numerous potential factors that each contribute to disease susceptibility, progression, and severity. Many recent detailed reviews have been published on mechanisms involving insulin resistance, dysregulation of microRNAs, and increased reactive oxygen species, as well as causes including both modifiable and non-modifiable risk factors. As such, the focus of the current review is to highlight aspects of each of these topics and to provide specific examples of recent advances in each area.

Citing Articles

Heart Failure and Osteoporosis: Shared Challenges in the Aging Population.

Spoladore R, Ciampi C, Ossola P, Sultana A, Spreafico L, Farina A J Cardiovasc Dev Dis. 2025; 12(2).

PMID: 39997503 PMC: 11856909. DOI: 10.3390/jcdd12020069.


Non-Invasive Assessment of the Intraventricular Pressure Using Novel Color M-Mode Echocardiography in Animal Studies: Current Status and Future Perspectives in Veterinary Medicine.

Mandour A, Farag A, Helal M, El-Masry G, Al-Rejaie S, Takahashi K Animals (Basel). 2023; 13(15).

PMID: 37570261 PMC: 10417806. DOI: 10.3390/ani13152452.


Role of vascular endothelial growth factor B in nonalcoholic fatty liver disease and its potential value.

Li Y, Xin L, Zhao Y, Li S, Li Y World J Hepatol. 2023; 15(6):786-796.

PMID: 37397934 PMC: 10308292. DOI: 10.4254/wjh.v15.i6.786.


Nanoformulations for the Delivery of Dietary Anthocyanins for the Prevention and Treatment of Diabetes Mellitus and Its Complications.

Nunes A, Costa E, Alves G, Silva L Pharmaceuticals (Basel). 2023; 16(5).

PMID: 37242519 PMC: 10221011. DOI: 10.3390/ph16050736.


Cyp2e1 knockdown attenuates high glucose-induced apoptosis and oxidative stress of cardiomyocytes by activating PI3K/Akt signaling.

Wang J, Yang H, Wang C, Kan C Acta Diabetol. 2023; 60(9):1219-1229.

PMID: 37195324 DOI: 10.1007/s00592-023-02110-2.


References
1.
Bedi Jr K, Snyder N, Brandimarto J, Aziz M, Mesaros C, Worth A . Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure. Circulation. 2016; 133(8):706-16. PMC: 4779339. DOI: 10.1161/CIRCULATIONAHA.115.017545. View

2.
Singh M, Arora R . Newer Therapies for Management of Stable Ischemic Heart Disease With Focus on Refractory Angina. Am J Ther. 2015; 23(6):e1842-e1856. DOI: 10.1097/MJT.0000000000000187. View

3.
Dempsey P, Owen N, Yates T, Kingwell B, Dunstan D . Sitting Less and Moving More: Improved Glycaemic Control for Type 2 Diabetes Prevention and Management. Curr Diab Rep. 2016; 16(11):114. DOI: 10.1007/s11892-016-0797-4. View

4.
Esler M . Mental stress and human cardiovascular disease. Neurosci Biobehav Rev. 2016; 74(Pt B):269-276. DOI: 10.1016/j.neubiorev.2016.10.011. View

5.
Hayward R, Reaven P, Wiitala W, Bahn G, Reda D, Ge L . Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2015; 372(23):2197-206. DOI: 10.1056/NEJMoa1414266. View